On Oct 31, major Wall Street analysts update their ratings for $Tenet Healthcare (THC.US)$, with price targets ranging from $183 to $217.
Goldman Sachs analyst Jamie Perse maintains with a buy rating, and adjusts the target price from $173 to $196.
BofA Securities analyst Joanna Gajuk maintains with a buy rating, and maintains the target price at $189.
UBS analyst A.J. Rice maintains with a buy rating, and adjusts the target price from $164 to $217.
RBC Capital analyst Ben Hendrix maintains with a buy rating, and adjusts the target price from $136 to $183.
Truist Financial analyst David S Macdonald maintains with a buy rating, and adjusts the target price from $180 to $190.
Furthermore, according to the comprehensive report, the opinions of $Tenet Healthcare (THC.US)$'s main analysts recently are as follows:
Tenet Healthcare displayed a robust performance across its various segments for the third quarter, particularly noting strong results from the hospital segment, with the USPI segment meeting expectations. The company is focusing on channeling investments towards the USPI segment as its primary capital allocation, while also continuing to seek growth opportunities within its hospitals, especially after refining its portfolio through a series of divestitures.
Tenet Healthcare demonstrated a notable recovery from previous weaknesses in the hospital segment, underscored by a robust third-quarter performance and an upward revision of future guidance. The company's preliminary outlook for 2025 indicates a persistence of robust volume trends into the upcoming year, alongside ongoing expansion of capacity.
Here are the latest investment ratings and price targets for $Tenet Healthcare (THC.US)$ from 5 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.